المؤلفون: Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France., Balar AV; Perlmutter Cancer Center at NYU Langone Health, New York, New York., Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, Connecticut., Kalebasty AR; University of California Irvine, Irvine, California., Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington., Fléchon A; Centre Léon Bérard, Lyon, France., Jain RK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Swami U; Huntsman Cancer Hospital, Salt Lake City, Utah., Bupathi M; Rocky Mountain Cancer Centers, Littleton, Colorado., Barthélémy P; Hôpitaux Universitaires de Strasbourg, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Beuzeboc P; Hôpital Foch, Suresnes, France., Palmbos P; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan., Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Pouessel D; Institut Claudius Regaud/IUCT-Oncopole, Toulouse, France., Sternberg CN; Weill Cornell Medicine, New York, New York., Tonelli J; Gilead Sciences, Inc., Parsippany, New Jersey., Sierecki M; Gilead Sciences, Inc, Foster City, California., Zavodovskaya M; Gilead Sciences, Inc, Foster City, California., Elboudwarej E; Gilead Sciences, Inc, Foster City, California., Diehl L; Gilead Sciences, Inc, Foster City, California., Jürgensmeier JM; Gilead Sciences, Inc, Foster City, California., Tagawa ST; Weill Cornell Medicine, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 01; Vol. 30 (15), pp. 3179-3188.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cell Adhesion Molecules*/metabolism , Antigens, Neoplasm* , Antibodies, Monoclonal, Humanized*/therapeutic use , Camptothecin*/analogs & derivatives , Camptothecin*/therapeutic use , Immunoconjugates*/therapeutic use, Humans ; Female ; Male ; Aged ; Middle Aged ; Aged, 80 and over ; Adult ; Biomarkers, Tumor/metabolism ; Urologic Neoplasms/drug therapy ; Urologic Neoplasms/pathology ; Urologic Neoplasms/mortality ; Urologic Neoplasms/metabolism ; Treatment Outcome ; Neoplasm Staging

المؤلفون: Msaouel P; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: PMsaouel@mdanderson.org., Sweis RF; University of Chicago Medicine, Chicago, IL, USA., Bupathi M; Rocky Mountain Cancer Centers - Littleton, Littleton, CO, USA., Heath E; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Goodman OB Jr; Comprehensive Cancer Centers of Nevada - Southwest, Las Vegas, NV, USA., Hoimes CJ; Duke University Hospital, Durham, NC, USA., Milowsky MI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Davis N; Vanderbilt - Ingram Cancer Center, Nashville, TN, USA., Kalebasty AR; University of California Irvine, Irvine, CA, USA., Picus J; Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO, USA., Shaffer D; New York Oncology Hematology - Albany Medical Center, Albany, NY, USA., Mao S; Allegheny General Hospital, Pittsburgh, PA, USA., Adra N; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Yorio J; Texas Oncology - Austin Central, Austin, TX, USA., Gandhi S; Florida Cancer Specialists and Research Institute - North Region (SCRI), Tampa Bay, FL, USA., Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Siefker-Radtke A; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang R; Mirati Therapeutics, Inc., San Diego, CA, USA., Latven L; Mirati Therapeutics, Inc., San Diego, CA, USA., Olson P; Mirati Therapeutics, Inc., San Diego, CA, USA., Chin CD; Mirati Therapeutics, Inc., San Diego, CA, USA., Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, USA., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH, USA., Iyer G; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 933-943. Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/secondary , Carcinoma, Transitional Cell*/pathology , Carcinoma, Transitional Cell*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Aged ; Male ; Female ; Middle Aged ; Aged, 80 and over ; Adult ; Neoplasm Metastasis ; Urologic Neoplasms/drug therapy ; Urologic Neoplasms/pathology ; Urologic Neoplasms/mortality ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology

المؤلفون: Maldonado E; University of California, San Francisco, San Francisco, California., Rathmell WK; Vanderbilt University Medical Center, Nashville, Tennessee., Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts., Takebe N; National Cancer Institute, Bethesda, Maryland., Rodon J; Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas., Mahalingam D; Northwestern University, Evanston, Illinois., Trikalinos NA; Washington University St. Louis, St. Louis, Missouri., Kalebasty AR; University of California, Irvine, Irvine, California., Parikh M; University of California, Davis, Davis, California., Boerner SA; Yale University, New Haven, Connecticut., Balido C; University of California, San Francisco, San Francisco, California., Krings G; University of California, San Francisco, San Francisco, California., Burns TF; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Bergsland EK; University of California, San Francisco, San Francisco, California., Munster PN; University of California, San Francisco, San Francisco, California., Ashworth A; University of California, San Francisco, San Francisco, California., LoRusso P; Yale University, New Haven, Connecticut., Aggarwal RR; University of California, San Francisco, San Francisco, California.

المصدر: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1793-1801.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Histone-Lysine N-Methyltransferase*/genetics , Protein-Tyrosine Kinases*/antagonists & inhibitors , Protein-Tyrosine Kinases*/genetics , Cell Cycle Proteins*/genetics , Cell Cycle Proteins*/antagonists & inhibitors , Pyrazoles*/therapeutic use , Pyrazoles*/adverse effects , Pyrazoles*/pharmacology, Humans ; Middle Aged ; Male ; Aged ; Female ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/pathology ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/pathology ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/genetics ; Kidney Neoplasms/pathology ; Pyrimidinones/therapeutic use ; Pyrimidinones/pharmacology ; Pyrimidinones/administration & dosage ; Mutation

المؤلفون: Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France., Kalebasty AR; University of California, Irvine, CA, USA., Fléchon A; Centre Léon Bérard, Lyon, France., Jain RK; H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Gupta S; Division of Oncology, Department of Medicine, University of Utah's Huntsman Cancer Institute, UT, USA., Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO, USA., Beuzeboc P; Hôpital Foch, Suresnes, France., Palmbos P; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Balar AV; Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Pouessel D; Institut Claudius Regaud/Cancer Comprehensive Center, IUCT, Oncopole, Toulouse, France., Sternberg CN; Weill Cornell Medicine, New York, NY, USA., Tonelli J; Gilead Sciences, Inc., Parsippany, NJ, USA., Sierecki M; Gilead Sciences, Inc., Parsippany, NJ, USA., Zhou H; Gilead Sciences, Inc., Parsippany, NJ, USA., Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Barthélémy P; Hôpitaux Universitaires de Strasbourg/Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Bangs R; Patient Advocate, Pittsford, New York, NY, USA., Tagawa ST; Weill Cornell Medicine, New York, NY, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Jun 05, pp. 1-11. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

المؤلفون: Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA., Lythgoe MP; Department of Surgery and Cancer, Imperial College, London, Hammersmith Hospital, London, United Kingdom., Kalebasty AR; Chao Family Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, Orange, CA.

المصدر: JCO oncology practice [JCO Oncol Pract] 2024 Apr; Vol. 20 (4), pp. 457-459. Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Motion Pictures* , Neoplasms*/complications , Neoplasms*/epidemiology , Neoplasms*/therapy, Humans ; Medical Oncology

المؤلفون: Mar N; Division of Hematology/Oncology, University of California Irvine, Orange, CA. Electronic address: marn@hs.uci.edu., Dwabe S; Division of Hematology/Oncology, University of California Irvine, Orange, CA., Baranda MN; Norton Cancer Institute, Louisville, KY., Zarrabi KK; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Eturi A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Gulati S; Division of Hematology/Oncology, University of California Davis, Sacramento, CA., Parikh M; Division of Hematology/Oncology, University of California Davis, Sacramento, CA., Seyedin SN; Department of Radiation Oncology, University of California Irvine, Orange, CA., Kalebasty AR; Division of Hematology/Oncology, University of California Irvine, Orange, CA.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Apr; Vol. 22 (2), pp. 217-223. Date of Electronic Publication: 2023 Nov 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Prostate-Specific Antigen* , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology, Male ; Humans ; Retrospective Studies ; Treatment Outcome ; Cyclophosphamide

المؤلفون: Yazdanpanah O; Division of Hematology and Oncology, Internal Medicine Department, University of California Irvine, Orange, California, USA., Mahadevan A; Division of Hematology and Oncology, Internal Medicine Department, University of California Irvine, Orange, California, USA., Sharma A; Division of Hematology/Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, Michigan, USA., Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, California, USA., Kalebasty AR; Division of Hematology and Oncology, Internal Medicine Department, University of California Irvine, Orange, California, USA.

المصدر: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6845. Date of Electronic Publication: 2023 Dec 26.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Spinal Cord Compression*/etiology , Spinal Cord Compression*/therapy , Spinal Cord Compression*/mortality , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/mortality , Hospitals, Teaching*, Humans ; Male ; United States/epidemiology ; Aged ; Retrospective Studies ; Middle Aged ; Hospitalization/statistics & numerical data ; Hospitalization/economics ; Aged, 80 and over

المؤلفون: Grant CR; Department of Medicine, University of California Irvine Medical Center, Orange, CA, USA., de Kouchkovsky D; Department of Dermatology, University of California - San Diego, La Jolla, CA, USA., Kalebasty AR; Department of Hematology/Oncology, University of California Irvine Medical Center, Orange, CA, USA., Mar N; Department of Hematology/Oncology, University of California Irvine Medical Center, Orange, CA, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Oct; Vol. 29 (7), pp. 1789-1792. Date of Electronic Publication: 2023 Jul 04.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*/drug therapy, Humans ; Cellulitis/chemically induced ; Antibodies, Monoclonal/adverse effects

المؤلفون: Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA, USA., Kalebasty AR; Division of Hematology/Oncology, UC Irvine Medical Center, Orange, CA, USA.

المصدر: Rare tumors [Rare Tumors] 2023 Jul 14; Vol. 15, pp. 20363613231189984. Date of Electronic Publication: 2023 Jul 14 (Print Publication: 2023).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101526926 Publication Model: eCollection Cited Medium: Print ISSN: 2036-3605 (Print) Linking ISSN: 20363605 NLM ISO Abbreviation: Rare Tumors Subsets: PubMed not MEDLINE

المؤلفون: Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL., Tombal B; Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium., Saad F; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Quebec, Canada., Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Department of Medicine, Meyer Cancer Center, New York-Presbyterian Hospital, New York, NY., Crawford ED; UC San Diego School of Medicine, San Diego, CA., Shore N; Carolina Urologic Research Center/Genesis Care, Myrtle Beach, SC., Kopyltsov E; Clinical Oncological Dispensary of Omsk Region, Omsk, Russian Federation., Kalebasty AR; University of California Irvine, Division of Hematology/Oncology, Orange, CA., Bögemann M; Department of Urology, Münster University Medical Center, Münster, Germany., Ye D; Fudan University Shanghai Cancer Center, Xuhui District, Shanghai, China., Cruz F; Núcleo de Pesquisa e Ensino da Rede São Camilo, São Paulo, Brazil., Suzuki H; Toho University Sakura Medical Center, Chiba, Japan., Kapur S; Bayer SEA, Singapore., Srinivasan S; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ., Verholen F; Bayer Consumer Care AG, Basel, Switzerland., Kuss I; Bayer AG, Berlin, Germany., Joensuu H; Orion Corporation, Espoo, Finland., Smith MR; Massachusetts General Hospital Cancer Center, Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jul 10; Vol. 41 (20), pp. 3595-3607. Date of Electronic Publication: 2023 Feb 16.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology, Male ; Humans ; Docetaxel ; Androgen Antagonists/adverse effects ; Androgens/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects